Search
Filter Results
- Resource Type
- Article1
- Journal1
- Journal Digital1
- Article Type
- English Abstract1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Biull Eksp Biol Med1
Search Results
Sort by
- ArticleBaryshnikov AIu, Radzikhovskaia RM, Morozova LF, Slavina EG, Belianchikova NI.Biull Eksp Biol Med. 1977 Jun;83(6):719-21.The immune antimyeloblast serum (AMS) was obtained from horses immunized with white blood cells from patients suffering from chronic myeloid leukemia (CML) at the blast crisis stage; the serum was completely absorbed with normal red blood cells and white blood cells (WBC). The absorbed antiserum remained cytotoxic to blast cells from 20 of 42 patients with CML at the blast crisis stage. AMS failed to react with the WBC from patients with CML in its chronic phase, and from patients with other types of leukemia Morphological studies indicated a possibility of identification of the antigen associated with myeloblasts from the blood of patients with CML blast crisis, by means to AMS.